U.S. pharma huge copyright scrapped two experimental weight loss supplements previous year—a at the time-everyday capsule, lotiglipron, resulting from elevated liver enzymes and a twice-daily tablet, danuglipron, on account of potent Unintended effects—but CEO Albert Bourla has reported the company is set to “play and earn” in the weight pr